PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91025C00025SBIR fy25 concept AWARD development of — Merlin Biotech Inc

Merlin Biotech Inc holds $355K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 55 offers. Set-aside status: SBA. Recompete timing centers on the Sep 21, 2026 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Merlin Biotech Inc

Recipient

Sep 21, 2026

PoP end

$355K

Obligated

$355K

Potential

541715

NAICS

AN12

PSC

SBA

Set-aside

55 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Merlin Biotech Inc — $90

Contract facts

SBA

Contract number75N91025C00025

AgencyNih Nci

Awarding officeNih Nci

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentMerlin Biotech Inc

CAGE9K6A1

UEIU33SZN8R3966

NAICS541715

PSCAN12

Place of performancePHILADELPHIA PA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

Related solicitation75N91024R00013

PoP startSep 22, 2025

PoP end (current)Sep 21, 2026

Obligated$355K

Current value$355K

Potential value$355K

SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL MURINE MODEL is a federal SBA award for Nih Nci held by Merlin Biotech Inc. Estimated value $355K ($355K obligated). Current period of performance ends Sep 21, 2026. Last award drew 55 bidders. Place of performance: PHILADELPHIA PA. Related solicitation 75N91024R00013.

SBIR FY25 CONCEPT AWARD, DEVELOPMENT OF AN IMMUNOTHERAPY FOR EWING SARCOMA USING A NOVEL MURINE MODEL

Recompete timing

Public

● Expiring in 14 days

Current PoP ends Sep 21, 2026 (14 days remaining). Agencies typically plan 12–18 months ahead — at 0.5 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Merlin Biotech Inc — $355K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$355K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91025C00025?

75N91025C00025 (SBIR fy25 concept AWARD development of) is a Nih Nci award with a potential value of $355K, currently held by Merlin Biotech Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91025C00025?

Nih Nci awarded 75N91025C00025 to Merlin Biotech Inc (potential $355K).

Who is the incumbent on 75N91025C00025?

Merlin Biotech Inc is the incumbent with $355K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Sep 21, 2026.

When does Merlin Biotech Inc’s 75N91025C00025 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 21, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91025C00025 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Sep 16, 2025